Month: June 2018

Advances in Neurodegenerative Disease Research and Therapy

Keystone Resort, Keystone, Colorado, USA Antibody-enzyme fusions degrade pathogenic glycogen in Lafora disease and demonstrate a novel cell-penetrating platform for treating neurological disorders Kathryn Brewer1, Annette Uittenbogaard1, Grant Austin1, John McCarthy1, Anna DePaoli-Roach2, Peter J. Roach2, Brad Hodges3, James R. Pauly3, Tracy McKnight3, Dustin D. Armstrong3*, Matthew S. Gentry1   1University of Kentucky, 2Indiana University, 3Valerion Therapeutics *dustin.armstrong@valerion.com   […]READ MORE...